Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.
about
Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assayImmunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialImmunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccinePersistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers.Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccAge-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiencySerologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic.Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharideOptimizing strategies for meningococcal C disease vaccination in Valencia (Spain).Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagersHumoral immune responses to Neisseria meningitidis in children.Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroadsAssignment of additional anticapsular antibody concentrations to the Neisseria meningitidis group A, C, Y, and W-135 meningococcal standard reference serum CDC1992.Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine.Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.Importance of complement source in measuring meningococcal bactericidal titers.Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing.Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study.Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescentsSerum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults.Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.Subsets of memory CD4+ T cell and bactericidal antibody response to Neisseria meningitidis serogroup C after immunization of HIV-infected children and adolescents.Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding proteinEarly appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine
P2860
Q28344521-6968D92C-B984-425C-B0F9-447183A011E8Q28650557-6E54A551-91FC-4731-AF86-60307EFE6C8DQ28749695-86BCD898-D8CC-4C39-90CA-5AB4014EDD56Q30210120-AB813BE1-7A20-4EFE-9E3E-13D71520D1F9Q33334377-487E12F8-1F0B-4B24-934E-52D5A5C92BC7Q33601899-1ABBFE38-99E8-4E8F-A4B2-8DF6212BEFECQ33603065-7159C841-5240-49C7-BF09-C6663831C0BFQ33613482-91FAB355-A5EE-4155-A641-8B5500E710AEQ33754255-86524DCD-BAEA-4857-BAB6-60D9B2EBF5EFQ33768741-02C564FF-B6BC-4C73-A208-E588AE1239E7Q33769150-24C57054-2EB3-412A-BB09-5AB4F83455DCQ33788581-793C7517-7DB4-44B0-B114-6B2A58B2F3AAQ33788651-733FD316-7BD5-4404-87E6-B187603C4AA8Q33799111-7E5C24C4-82E8-44A2-BB6A-1C79625A2024Q33806774-DB9E1047-5BAA-4C3B-8411-033CEE1283D3Q33867340-3CDF7C3F-A367-42B9-A0A2-A0458163B953Q33910760-23C8F33D-6E17-43BB-A323-DD26C5FF8D8DQ33916408-E7FE2F39-8F44-489F-8BAE-6E99DCC57625Q33943418-20FA43BF-95C9-43B3-B139-E889B6A43548Q33959308-EA3EAD8B-D860-4DD5-8029-9A5EA133CAE3Q33962704-138C04F7-847E-49E4-AB7D-7AD6125C7AE8Q33968762-13A1E909-9A97-4710-BCD1-B2CD2819FB53Q33999159-03B24325-531D-4DF6-8E10-2D2F8E77B118Q34006352-9925D901-8CE8-456D-88F2-C7E92E62A115Q34007332-B0C8CF67-72FA-4208-B90C-DC7B0A2A2BFFQ34034071-9287D66E-8969-4CBF-8200-9EA1396A14F5Q34126015-CBAA4EB3-D107-422A-BFA8-14EC8047BF40Q34131154-72CF9BC7-340A-4797-B558-D9813777D636Q34232221-797C921B-D617-4D68-8325-53F8DAC2DCA5Q34531872-9FEF16B2-77AA-45D8-9A88-6BD5B947057CQ34606343-F03D8849-E88C-4116-94FC-A278DBDCC9FEQ34627685-750FFF63-C7B6-4910-AF82-F5C2CF99E9D5Q34694957-246347D7-C8B1-4283-8CBF-0AF2AB4846DEQ34738958-27DEB789-7507-4AEA-82C0-0AF73D66B65EQ34739082-E25F0A12-A2B1-4F15-8DBC-92F34E7E913FQ34757967-DA3C217F-91E7-4795-8FF0-E340EC5298F7Q34916886-DF3D82F1-AC9E-4D5A-8796-309F6D691103Q34975007-CAECC76B-4F69-4161-ACE1-E982B2C32DECQ35013077-45EAA526-2D3A-4F9D-BC6E-FD0D99A77B2AQ35066182-23CEB700-6EE2-446C-8780-DF7F7CA8D526
P2860
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Standardization and a multilab ...... e Multilaboratory Study Group.
@ast
Standardization and a multilab ...... e Multilaboratory Study Group.
@en
type
label
Standardization and a multilab ...... e Multilaboratory Study Group.
@ast
Standardization and a multilab ...... e Multilaboratory Study Group.
@en
prefLabel
Standardization and a multilab ...... e Multilaboratory Study Group.
@ast
Standardization and a multilab ...... e Multilaboratory Study Group.
@en
P2093
P2860
P1476
Standardization and a multilab ...... he Multilaboratory Study Group
@en
P2093
Carlone GM
Donaldson KB
Gheesling LL
Harakeh HS
Kriz-Kuzemenska P
P2860
P304
P577
1997-03-01T00:00:00Z